This article has Open Peer Review reports available.
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
© Tang et al.; licensee BioMed Central Ltd. 2013
Received: 14 December 2011
Accepted: 19 March 2013
Published: 9 May 2013
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|14 Dec 2011||Submitted||Original manuscript|
|28 Mar 2012||Reviewed||Reviewer Report - Vivek Roy|
|12 Nov 2012||Reviewed||Reviewer Report - Valentina Nekljudova|
|26 Dec 2012||Author responded||Author comments - Li Chen Tang|
|Resubmission - Version 2|
|26 Dec 2012||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|19 Mar 2013||Author responded||Author comments - Li Chen Tang|
|Resubmission - Version 5|
|19 Mar 2013||Submitted||Manuscript version 5|
|19 Mar 2013||Editorially accepted|
|9 May 2013||Article published||10.1186/1471-2407-13-232|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.